CASI Pharmaceuticals, Inc. (CASI)

0.8565 +0.06 (+7.06%) USD  |  NASDAQ  |  Feb 20, 12:37
More

CASI Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for CASI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Sinovac Biotech Ltd. --
Zai Lab Ltd. Upgrade
WuXi Biologics (Cayman), Inc. --
Viva Biotech Holdings --
Ascletis Pharma, Inc. --